1214344-87-2 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 3-chloro-4,5-difluorobenzoate is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical industry, Methyl 3-chloro-4,5-difluorobenzoate is utilized as an intermediate in the production of agrochemicals, helping to create compounds that can protect crops and enhance agricultural productivity.
Used in Research and Development:
Methyl 3-chloro-4,5-difluorobenzoate is also used in research and development settings to explore its potential applications and to understand its chemical properties, which can lead to the discovery of new uses and products.
It is important to handle Methyl 3-chloro-4,5-difluorobenzoate with care, as it may cause irritation to the skin, eyes, and respiratory system upon contact or inhalation.
Check Digit Verification of cas no
The CAS Registry Mumber 1214344-87-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,4,3,4 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1214344-87:
(9*1)+(8*2)+(7*1)+(6*4)+(5*3)+(4*4)+(3*4)+(2*8)+(1*7)=122
122 % 10 = 2
So 1214344-87-2 is a valid CAS Registry Number.
1214344-87-2Relevant academic research and scientific papers
PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS
-
Paragraph 0246, (2021/02/26)
The present invention discloses compounds according to Formula (I) wherein R1, R2, and Cy are as defined herein. The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of allergic diseases, inflammatory diseases, metabolic diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IFNα, IL12 and/or IL23 by administering the compound of the invention.
NOVEL COMPOUNDS FOR MODULATION OF ROR-GAMMA ACTIVITY
-
Paragraph 00645, (2014/03/22)
The present invention relates to aryl sulfones and related compounds that are modulators of ROR-gamma receptors. The invention also provides pharmaceutical compositions comprising these modulators, and methods of modulating ROR-gamma receptors using them. Also provided are methods of using aryl sulfones and related compounds as modulators of ROR-gamma to treat ROR-gamma mediated diseases
